Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The following cleansing notice was lodged with ASX on December 1, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 26…
Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting
As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems' President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as…
Appendix 2A Application for quotation of +securities
The following Appendix 2A was announced via ASX on 25 Nov 2021. Please click to review full announcement.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The following cleansing notice was lodged with ASX on November 25, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 19…
IBXO Options Underwriting Agreement — US Based Investor
Imagion Biosystems is pleased to announce it has entered into an options underwriting agreement (Underwriting Agreement) with Mercer Street Global…
Appendix 3Y Change of Director's Interest Notice
The document "Appendix 3Y Change of Director's Interest Notice" was lodged with ASX on 22 November, 2021. Please click to review the full announcement at ASX.
Application for quotation of +securities
The document "Application for quotation of +securities" was lodged with ASX on November 18, 2021. Please click to review the full announcement at ASX.
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
The following cleansing notice was lodged with ASX on 18 November 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 12…
Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 29 October 2021 and 4 November 2021 the Company issued 7,075,649 fully paid…
Appendix 3Y Change of Director's Interest Notice
The document "Appendix 3Y Change of Director's Interest Notice" was lodged with ASX on 11 November 2021. Please click the review the full announcement at ASX.